Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -137,950 | -100,564 | -64,234 | -36,846 | -67,995 |
| Depreciation Amortization | 406 | 94 | 38 | 19 | 56 |
| Other Working Capital | 14,809 | 6,367 | 3,204 | 5,132 | -14,132 |
| Other Operating Activity | 15,901 | 11,155 | 7,292 | 3,589 | 7,320 |
| Operating Cash Flow | $-106,834 | $-82,948 | $-53,700 | $-28,106 | $-74,751 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -280 | -42 | N/A | N/A | -9 |
| Purchase Of Investment | -318,173 | -236,079 | N/A | N/A | N/A |
| Investing Cash Flow | $-318,453 | $-236,121 | $N/A | $N/A | $-9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,261 | 1,031 | 595 | 460 | 334,031 |
| Financing Cash Flow | $32,261 | $1,031 | $595 | $460 | $334,031 |
| Beginning Cash Position | 489,711 | 489,711 | 489,711 | 489,711 | 230,440 |
| End Cash Position | 96,685 | 171,673 | 436,606 | 462,065 | 489,711 |
| Net Cash Flow | $-393,026 | $-318,038 | $-53,105 | $-27,646 | $259,271 |
| Free Cash Flow | |||||
| Operating Cash Flow | -106,834 | -82,948 | -53,700 | -28,106 | -74,751 |
| Capital Expenditure | -280 | -42 | 0 | 0 | -71 |
| Free Cash Flow | -107,114 | -82,990 | -53,700 | -28,106 | -74,822 |